FAQ/Help |
Calendar |
Search |
Today's Posts |
01-20-2010, 05:06 PM | #1 | ||
|
|||
Member
|
"Novartis said on Wednesday it had filed FTY720, also known as fingolimod, for approval in the United States and European Union at the lower dose of 0.5 milligrams, which data showed had the best benefit-risk profile."
|
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
Chrysler Filed Bankruptcy | The Stumble Inn | |||
EMEA...EMEA Recommends Warnings / Ergot-derived Dopamine Agonists, Europed Dopamine | Parkinson's Disease | |||
Europoe/UK...Clinical Trials Directive Hammered at EMEA Meeting in London | Parkinson's Disease | |||
Husband Filed for Divorce | Bipolar Disorder | |||
Requip XR...GLK filed for approval with the FDA | Parkinson's Disease |